Oxford Global Conferences is proud to present the 3rd Annual Proteins Congress 2010, which is to be held on the 27th & 28th October in Berlin. The congress is the single most focused event in Europe dedicated to key technological and scientific trends in Proteins in the biopharmaceutical, pharmaceutical and biotech industry, as well as academic institutions.  It will also be co-located with our Vaccines Congress.

Biopharmaceutical products are the key to the future of the pharmaceutical market. Pharmaceutical and biotech companies are facing drastic consequences from the loss of patent cover for many blockbusters and there are continued challenges to produce replacement candidates. The biopharma market – antibodies & antibody alternatives, therapeutic proteins and vaccines – promises success in overcoming these challenges.

The 3^rd Proteins Congress seeks to address the current trends and business models in advancing protein and antibody therapeutics in the biopharma market.  The event will focus on the business, scientific and technological trends and addresses opportunities and challenges in developing enhanced protein and antibody drugs. Key topic areas include Protein Science, Protein Technologies, Expression, Characterisation, Engineering and Production and the future industry outlook of antibody and protein therapeutics.